133 related articles for article (PubMed ID: 38406848)
1. Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
Yan Y; Guo J; Wang X; Wang G; Fan Z; Yin D; Wang Z; Zhang F; Tian C; Gong W; Liu J; Lu J; Li Y; Ma C; Vicaut E; Montalescot G; Nie S;
Circulation; 2024 Apr; 149(16):1258-1267. PubMed ID: 38406848
[TBL] [Abstract][Full Text] [Related]
2. Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.
Bikdeli B; Erlinge D; Valgimigli M; Kastrati A; Han Y; Steg PG; Stables RH; Mehran R; James SK; Frigoli E; Goldstein P; Li Y; Shahzad A; Schüpke S; Mehdipoor G; Chen S; Redfors B; Crowley A; Zhou Z; Stone GW
Circulation; 2023 Oct; 148(16):1207-1219. PubMed ID: 37746717
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design of the RIGHT trial: A multicenter, randomized, double-blind, placebo-controlled trial of anticoagulation prolongation versus no anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Yan Y; Wang X; Guo J; Li Y; Ai H; Gong W; Que B; Zhen L; Lu J; Ma C; Montalescot G; Nie S
Am Heart J; 2020 Sep; 227():19-30. PubMed ID: 32663660
[TBL] [Abstract][Full Text] [Related]
4. Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.
Li Y; Liang Z; Qin L; Wang M; Wang X; Zhang H; Liu Y; Li Y; Jia Z; Liu L; Zhang H; Luo J; Dong S; Guo J; Zhu H; Li S; Zheng H; Liu L; Wu Y; Zhong Y; Qiu M; Han Y; Stone GW
Lancet; 2022 Nov; 400(10366):1847-1857. PubMed ID: 36351459
[TBL] [Abstract][Full Text] [Related]
5. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
[TBL] [Abstract][Full Text] [Related]
6. Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study.
Bai Z; Wang Z; Feng Q; Zhang Y; Zhang M; Hou A; Wu Y; Qin Z; Chai L
Braz J Med Biol Res; 2023; 56():e13013. PubMed ID: 37970924
[TBL] [Abstract][Full Text] [Related]
7. Single Bolus r-SAK Before Primary PCI for ST-Segment-Elevation Myocardial Infarction.
Chen P; Eikelboom JW; Tan C; Zhang W; Xu Y; Bai J; Wang J; Wang T; Gong X; Liu K; Chen X; Wang X; Zhu L; Zhao X; Yang N; Jiang J; Pu J; Zhao B; Chen Z; Li B; Wang G; Lu C; Ying L; Jiang M; Zhu X; Ma J; Dong Z; Li C; Zong J; Zhang F; Zhu J; Huang J; Kong X; Yu H; Li C;
Circ Cardiovasc Interv; 2024 Feb; 17(2):e013455. PubMed ID: 38258563
[TBL] [Abstract][Full Text] [Related]
8. Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study.
Yu XF; Chen HW; Xu J; Xu QZ; Zhang XH; Li BB; Xu BL; Ma LK
Front Cardiovasc Med; 2022; 9():932054. PubMed ID: 36386368
[TBL] [Abstract][Full Text] [Related]
9. STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial.
Van de Werf F; Ristić AD; Averkov OV; Arias-Mendoza A; Lambert Y; Kerr Saraiva JF; Sepulveda P; Rosell-Ortiz F; French JK; Musić LB; Vandenberghe K; Bogaerts K; Westerhout CM; Pagès A; Danays T; Bainey KR; Sinnaeve P; Goldstein P; Welsh RC; Armstrong PW;
Circulation; 2023 Aug; 148(9):753-764. PubMed ID: 37439219
[TBL] [Abstract][Full Text] [Related]
10. Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Aytekin A; Ndrepepa G; Neumann FJ; Menichelli M; Mayer K; Wöhrle J; Bernlochner I; Lahu S; Richardt G; Witzenbichler B; Sibbing D; Cassese S; Angiolillo DJ; Valina C; Kufner S; Liebetrau C; Hamm CW; Xhepa E; Hapfelmeier A; Sager HB; Wustrow I; Joner M; Trenk D; Fusaro M; Laugwitz KL; Schunkert H; Schüpke S; Kastrati A
Circulation; 2020 Dec; 142(24):2329-2337. PubMed ID: 33115278
[TBL] [Abstract][Full Text] [Related]
11. Bivalirudin versus unfractionated heparin in patients with myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials.
Al-Abdouh A; Mhanna M; Jabri A; Madanat L; Alhuneafat L; Mostafa MR; Kundu A; Gupta V
Cardiovasc Revasc Med; 2024 Apr; 61():52-61. PubMed ID: 37872022
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Insights from the ORBI registry.
Auffret V; Leurent G; Boulmier D; Bedossa M; Zabalawi A; Hacot JP; Coudert I; Filippi E; Castellant P; Rialan A; Rouault G; Druelles P; Boulanger B; Treuil J; Avez B; Le Guellec M; Gilard M; Le Breton H
Arch Cardiovasc Dis; 2016 Dec; 109(12):696-707. PubMed ID: 27818120
[TBL] [Abstract][Full Text] [Related]
14. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
Ferguson JJ; Califf RM; Antman EM; Cohen M; Grines CL; Goodman S; Kereiakes DJ; Langer A; Mahaffey KW; Nessel CC; Armstrong PW; Avezum A; Aylward P; Becker RC; Biasucci L; Borzak S; Col J; Frey MJ; Fry E; Gulba DC; Guneri S; Gurfinkel E; Harrington R; Hochman JS; Kleiman NS; Leon MB; Lopez-Sendon JL; Pepine CJ; Ruzyllo W; Steinhubl SR; Teirstein PS; Toro-Figueroa L; White H;
JAMA; 2004 Jul; 292(1):45-54. PubMed ID: 15238590
[TBL] [Abstract][Full Text] [Related]
15. Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population.
Wang H; Liang Z; Li Y; Li B; Liu J; Hong X; Lu X; Wu J; Zhao W; Liu Q; An J; Li L; Pu F; Ming Q; Han Y
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28083915
[TBL] [Abstract][Full Text] [Related]
16. Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction.
James S; Koul S; Andersson J; Angerås O; Bhiladvala P; Calais F; Danielewicz M; Fröbert O; Grimfjärd P; Götberg M; Henareh L; Ioanes D; Jensen J; Linder R; Lindroos P; Omerovic E; Panayi G; Råmunddal T; Sarno G; Ulvenstam A; Völtz S; Wagner H; Wikström H; Östlund O; Erlinge D
Circ Cardiovasc Interv; 2021 Dec; 14(12):e008969. PubMed ID: 34903034
[TBL] [Abstract][Full Text] [Related]
17. Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Patient-Level Analysis of 2 Randomized Trials.
Dangas GD; Schoos MM; Steg PG; Mehran R; Clemmensen P; van 't Hof A; Prats J; Bernstein D; Deliargyris EN; Stone GW
Circ Cardiovasc Interv; 2016 May; 9(5):e003272. PubMed ID: 27165710
[TBL] [Abstract][Full Text] [Related]
18. Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial.
Vlachojannis GJ; Wilschut JM; Vogel RF; Lemmert ME; Delewi R; Diletti R; van der Waarden NWPL; Nuis RJ; Paradies V; Alexopoulos D; Zijlstra F; Montalescot G; Angiolillo DJ; Krucoff MW; Van Mieghem NM; Smits PC
Circulation; 2020 Dec; 142(24):2316-2328. PubMed ID: 33315489
[TBL] [Abstract][Full Text] [Related]
19. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial.
Montalescot G; Zeymer U; Silvain J; Boulanger B; Cohen M; Goldstein P; Ecollan P; Combes X; Huber K; Pollack C; Bénezet JF; Stibbe O; Filippi E; Teiger E; Cayla G; Elhadad S; Adnet F; Chouihed T; Gallula S; Greffet A; Aout M; Collet JP; Vicaut E;
Lancet; 2011 Aug; 378(9792):693-703. PubMed ID: 21856483
[TBL] [Abstract][Full Text] [Related]
20. Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial.
; Steg PG; Jolly SS; Mehta SR; Afzal R; Xavier D; Rupprecht HJ; López-Sendón JL; Budaj A; Diaz R; Avezum A; Widimsky P; Rao SV; Chrolavicius S; Meeks B; Joyner C; Pogue J; Yusuf S
JAMA; 2010 Sep; 304(12):1339-49. PubMed ID: 20805623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
